InsidersTradesSigma

Thomas Christopher Gene

Cumul. flow

Total declarations

Company

—

▲ Purchases (0 ops.)

€84,519

▼ Sales (1 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

1

T+90 hit rate

40%

T+90 mean return

-11.7%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the detailed record of transactions filed by Thomas Christopher Gene. Director active across 1 company, notably Paycom Software, Inc.. Cumulatively, 7 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €85k. Activity tracked since 2 May 2023. The latest transaction was disclosed on 10 May 2024 (Retenue fiscale). Regulator: SEC (Form 4). All data is openly available.

Declarations7 total

●

Thomas Christopher Gene

Co-Chief Executive OfficerExecutives10 May 2024Paycom Software, Inc.

$52,71123SEC ↗

304 shares@ US$173.3912.1% of flowCommon StockSEC:0000950170-24-059650:0

◆

Thomas Christopher Gene

Co-Chief Executive OfficerExecutives1 Mar 2024Paycom Software, Inc.

22SEC ↗

7,236 shares0Common StockSEC:0000950170-24-025948:0

◆